Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection

Author: Stout Jason E  

Publisher: Informa Healthcare

ISSN: 1474-0338

Source: Expert Opinion on Drug Safety, Vol.3, Iss.3, 2004-05, pp. : 187-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content